BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31675723)

  • 1. Association of cancer center type with treatment patterns and overall survival for patients with sacral and spinal chordomas: an analysis of the National Cancer Database from 2004 to 2015.
    Wright CH; Wright J; Cioffi G; Hdeib A; Kasliwal MK; Kruchko C; Barnholtz-Sloan JS; Sloan AE
    J Neurosurg Spine; 2019 Nov; 32(2):311-320. PubMed ID: 31675723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chordomas of the Skull Base, Mobile Spine, and Sacrum: An Epidemiologic Investigation of Presentation, Treatment, and Survival.
    Zuckerman SL; Bilsky MH; Laufer I
    World Neurosurg; 2018 May; 113():e618-e627. PubMed ID: 29486315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Are the Conditional Survival and Functional Outcomes After Surgical Treatment of 115 Patients With Sacral Chordoma?
    Ji T; Guo W; Yang R; Tang X; Wang Y; Huang L
    Clin Orthop Relat Res; 2017 Mar; 475(3):620-630. PubMed ID: 26975382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sacral Insufficiency Fractures are Common After High-dose Radiation for Sacral Chordomas Treated With or Without Surgery.
    Osler P; Bredella MA; Hess KA; Janssen SJ; Park CJ; Chen YL; DeLaney TF; Hornicek FJ; Schwab JH
    Clin Orthop Relat Res; 2016 Mar; 474(3):766-72. PubMed ID: 26400251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
    Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sacral chordoma: a clinical review of 101 cases with 30-year experience in a single institution.
    van Wulfften Palthe ODR; Tromp I; Ferreira A; Fiore A; Bramer JAM; van Dijk NC; DeLaney TF; Schwab JH; Hornicek FJ
    Spine J; 2019 May; 19(5):869-879. PubMed ID: 30445184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients.
    Hsieh PC; Xu R; Sciubba DM; McGirt MJ; Nelson C; Witham TF; Wolinksy JP; Gokaslan ZL
    Spine (Phila Pa 1976); 2009 Sep; 34(20):2233-9. PubMed ID: 19752710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobile spine chordoma: results of 166 patients from the AOSpine Knowledge Forum Tumor database.
    Gokaslan ZL; Zadnik PL; Sciubba DM; Germscheid N; Goodwin CR; Wolinsky JP; Bettegowda C; Groves ML; Luzzati A; Rhines LD; Fisher CG; Varga PP; Dekutoski MB; Clarke MJ; Fehlings MG; Quraishi NA; Chou D; Reynolds JJ; Williams RP; Kawahara N; Boriani S
    J Neurosurg Spine; 2016 Apr; 24(4):644-51. PubMed ID: 26682601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Type of Treatment Facility With Overall Survival After a Diagnosis of Head and Neck Cancer.
    Carey RM; Fathy R; Shah RR; Rajasekaran K; Cannady SB; Newman JG; Ibrahim SA; Brant JA
    JAMA Netw Open; 2020 Jan; 3(1):e1919697. PubMed ID: 31977060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Treatment of Sacral Chordoma: En Bloc Resection with Negative Margins is a Determinant of the Long-Term Outcome.
    Colangeli S; Muratori F; Bettini L; Frenos F; Totti F; D'Arienzo A; Campo FR; Scoccianti G; Beltrami G; Campanacci DA; Capanna R
    Surg Technol Int; 2018 Nov; 33():343-348. PubMed ID: 30204925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the Role of Adjuvant Radiotherapy in the Management of Sacral and Vertebral Chordoma: Results from a National Database.
    Yolcu Y; Wahood W; Alvi MA; Kerezoudis P; Okuno SH; Foote RL; Bydon M
    World Neurosurg; 2019 Jul; 127():e1137-e1144. PubMed ID: 30995559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sacrectomy and adjuvant radiotherapy for the treatment of sacral chordomas: a single-center experience over 27 years.
    Dhawale AA; Gjolaj JP; Holmes L; Sands LR; Temple HT; Eismont FJ
    Spine (Phila Pa 1976); 2014 Mar; 39(5):E353-9. PubMed ID: 24365895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Oncologic Outcomes and Treatment-Related Toxicity of Carbon Ion Radiotherapy and En Bloc Resection for Sacral Chordoma.
    Yolcu YU; Zreik J; Wahood W; Bhatti AUR; Bydon M; Houdek MT; Rose PS; Mahajan A; Petersen IA; Haddock MG; Ahmed SK; Laack NN; Jethwa K; Jeans EB; Imai R; Yamada S; Foote RL
    JAMA Netw Open; 2022 Jan; 5(1):e2141927. PubMed ID: 34994795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors.
    Rotondo RL; Folkert W; Liebsch NJ; Chen YL; Pedlow FX; Schwab JH; Rosenberg AE; Nielsen GP; Szymonifka J; Ferreira AE; Hornicek FJ; DeLaney TF
    J Neurosurg Spine; 2015 Dec; 23(6):788-97. PubMed ID: 26340383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of intraoperative radiotherapy in the treatment of sacral chordoma.
    Jullien-Petrelli AC; García-Sabrido JL; Orue-Echebarria MI; Lozano P; Álvarez A; Serrano J; Calvo FM; Calvo-Haro JA; Lasso JM; Asencio JM
    Spine J; 2018 Apr; 18(4):632-638. PubMed ID: 28882523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sacral chordoma: retrospective review of 11 surgically treated cases].
    Jeanrot C; Vinh TS; Anract P; De Pinieux G; Ouaknine M; Forest M; Tomeno B
    Rev Chir Orthop Reparatrice Appar Mot; 2000 Nov; 86(7):684-93. PubMed ID: 11104990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of prognostic factors for survival in patients with primary spinal chordoma using the SEER Registry from 1973 to 2014.
    Pan Y; Lu L; Chen J; Zhong Y; Dai Z
    J Orthop Surg Res; 2018 Apr; 13(1):76. PubMed ID: 29625617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of sacral chordoma: prognostic variables for local recurrence and overall survival.
    Varga PP; Szövérfi Z; Fisher CG; Boriani S; Gokaslan ZL; Dekutoski MB; Chou D; Quraishi NA; Reynolds JJ; Luzzati A; Williams R; Fehlings MG; Germscheid NM; Lazary A; Rhines LD
    Eur Spine J; 2015 May; 24(5):1092-101. PubMed ID: 25533857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients.
    Bergh P; Kindblom LG; Gunterberg B; Remotti F; Ryd W; Meis-Kindblom JM
    Cancer; 2000 May; 88(9):2122-34. PubMed ID: 10813725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical markers predicting long-term recurrence following clival and spinal chordoma resection: a multicenter study.
    Ghaith AK; Akinduro OO; Alexander AY; Goyal A; Bon-Nieves A; de Macedo Filho L; Otamendi-Lopez A; Nathani KR; Abode-Iyamah K; Jentoft ME; Bendok BR; Clarke MJ; Link MJ; Van Gompel JJ; Quiñones-Hinojosa A; Bydon M
    Neurosurg Focus; 2023 Jun; 54(6):E15. PubMed ID: 37552641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.